ATE11285T1 - Pyrimidylthioharnstoffe, diese enthaltende arzneimittel und deren verwendung. - Google Patents

Pyrimidylthioharnstoffe, diese enthaltende arzneimittel und deren verwendung.

Info

Publication number
ATE11285T1
ATE11285T1 AT81102997T AT81102997T ATE11285T1 AT E11285 T1 ATE11285 T1 AT E11285T1 AT 81102997 T AT81102997 T AT 81102997T AT 81102997 T AT81102997 T AT 81102997T AT E11285 T1 ATE11285 T1 AT E11285T1
Authority
AT
Austria
Prior art keywords
substituents
general formula
compound
alkoxy
reacted
Prior art date
Application number
AT81102997T
Other languages
English (en)
Inventor
Wolfgang Dr. Dipl.-Chem Stenzel
Original Assignee
Beiersdorf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Aktiengesellschaft filed Critical Beiersdorf Aktiengesellschaft
Application granted granted Critical
Publication of ATE11285T1 publication Critical patent/ATE11285T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT81102997T 1980-04-30 1981-04-18 Pyrimidylthioharnstoffe, diese enthaltende arzneimittel und deren verwendung. ATE11285T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803016767 DE3016767A1 (de) 1980-04-30 1980-04-30 Pyrimidylthioharnstoffe, diese enthaltende arzneimittel und deren verwendung
EP81102997A EP0039037B1 (de) 1980-04-30 1981-04-18 Pyrimidylthioharnstoffe, diese enthaltende Arzneimittel und deren Verwendung

Publications (1)

Publication Number Publication Date
ATE11285T1 true ATE11285T1 (de) 1985-02-15

Family

ID=6101393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81102997T ATE11285T1 (de) 1980-04-30 1981-04-18 Pyrimidylthioharnstoffe, diese enthaltende arzneimittel und deren verwendung.

Country Status (5)

Country Link
EP (1) EP0039037B1 (de)
JP (1) JPS56169677A (de)
AT (1) ATE11285T1 (de)
CA (1) CA1152074A (de)
DE (2) DE3016767A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642053A1 (fr) * 1989-01-24 1990-07-27 Pilard Annick Fosse de reception et expedition de produit en vrac en " peseuse et melangeuse "

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2849537C2 (de) * 1978-11-15 1983-03-17 Beiersdorf Ag, 2000 Hamburg Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
DE3168252D1 (en) 1985-02-28
JPS56169677A (en) 1981-12-26
DE3016767A1 (de) 1981-11-05
EP0039037B1 (de) 1985-01-16
EP0039037A1 (de) 1981-11-04
CA1152074A (en) 1983-08-16

Similar Documents

Publication Publication Date Title
Weidner et al. Alkyl and aryl thiolsulfonates
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
IL73240A0 (en) Piperazinyl derivatives,their preparation and pharmaceutical compositions containing them
FR2416888A1 (fr) Nouveaux derives de phenyl-piperazine utiles comme medicaments
ES8307757A1 (es) "procedimiento para la preparacion de mandelonitrilos y derivados de acido mandelico".
ES481729A1 (es) Procedimiento para la preparacion de derivados de 1,2-dihi- droquinolein-2-onas.
ATE3289T1 (de) Alpha-azolylglykolderivate, ihre herstellung, sie enthaltende pflanzenwachstumsregulierende mittel und ihre verwendung.
ES459407A1 (es) Un procedimiento para la preparacion de un compuesto de pi- perazinilpirazina.
EP0050286A3 (en) Novel pharmaceutical guanidine derivatives
DE2965701D1 (en) 1-imidazol-2-ylidene-3-thienyl-urea derivatives, processes therefor, and pharmaceutical compositions
ATE11285T1 (de) Pyrimidylthioharnstoffe, diese enthaltende arzneimittel und deren verwendung.
GB1169945A (en) Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives
ATE35133T1 (de) N-substituierte (bis(hydroxymethyl)-methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ATE18667T1 (de) Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung.
IL48790A (en) Hydroxy-pyrimidines,their preparation and pharmaceutical compositions containing them
GB1193917A (en) Improvements in or relating to Heterocyclic Compounds and the Manufacture Thereof
ES357317A1 (es) Procedimiento para la preparacion de 3-amino -i,2-benziso- tiazoles n-disustituidos.
ATE40118T1 (de) Benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel.
FR2357563A1 (fr) Nouvelles 7h-pyrrolo(3,2-f) quinazoline-1,3-diamines substituees en position 7, leur procede de preparation et medicament les contenant
FR2566407B1 (fr) Nouveaux derives de l'isoxazoloquinoleine, procede de preparation, application a titre de medicaments, et compositions les renfermant
GB1426666A (en) Pyridine derivatives their preparation and pharmaceutical composi ions containing them
ES400624A1 (es) Procedimiento para la preparacion de derivados de acido pe-niciloico.
EP0027482A3 (de) Herbizide Pyridinsulfonylisothioharnstoffe, deren Herstellung und Verwendung, sie enthaltende Zusammensetzungen, Zwischenverbindungen für ihre Herstellung und Herstellung solcher Zwischenverbindungen
ES8105286A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina.
FR2364885A1 (fr) Acides phenoxyphenoxyvaleriques et leurs derives, compositions les renfermant et procede de leur utilisation comme herbicides

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee